The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Hemosol B0 solution for haemodialysis/haemofiltration

Baxter Holding B.V.PA2299/051/002

Main Information

Trade NameHemosol B0 solution for haemodialysis/haemofiltration
Active SubstancesMagnesium chloride hexahydrate
Calcium chloride dihydrate
Lactic acid
Sodium hydrogen carbonate
Sodium chloride
Sodium chloride
Calcium chloride dihydrate
Magnesium chloride hexahydrate
Sodium lactate
Sodium hydrogen carbonate
Dosage FormSolution for haemodialysis/haemofiltration
Licence HolderBaxter Holding B.V.
Licence NumberPA2299/051/002

Group Information



License statusAuthorised
Licence Issued11/06/1999
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back